[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Terrill SJ, Jackson CM, Greene HE, Lilly N, Maske CB, Vallejo S, et al
When patients with CNI toxicity or chronic fibrosis were switched from CNI to SRL-based regimen, a significant drop in hemoglobin was noted, despite improvement in allograft function [28]
Injection technique follows the same principles covered in our retatrutide injection guide and GLP-1 injection guide
Consistency: Keeping a consistent schedule helps keep the peaks and valleys of the medication level stable
8 Conclusion and future perspectives The chronic, relapsing nature of UC and the rising global prevalence of UC, especially in developed nations, necessitate the urgent need for effective therapeutic strategies
Weight loss plateaus on GLP-1 therapy are normal and typically last one to three weeks